- 专利标题: DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
-
申请号: EP13184888.9申请日: 2005-04-22
-
公开(公告)号: EP2708225B1公开(公告)日: 2018-12-26
- 发明人: Pipkin, James D , Mosher, Gerold L. , Hecker, Douglas B
- 申请人: CyDex Pharmaceuticals, Inc.
- 申请人地址: 3911 Sorrento Valley Boulevard Suite 110 San Diego, CA 92121 US
- 专利权人: CyDex Pharmaceuticals, Inc.
- 当前专利权人: CyDex Pharmaceuticals, Inc.
- 当前专利权人地址: 3911 Sorrento Valley Boulevard Suite 110 San Diego, CA 92121 US
- 代理机构: Harris, Jennifer Lucy
- 优先权: US564892P 20040423
- 主分类号: A61K9/12
- IPC分类号: A61K9/12 ; A61K9/14 ; C08B37/16
摘要:
An inhalable dry powder formulation containing SAE-CD and an active agent is provided. The formulation is adapted for administration by DPI. The SAE-CD serves as a carrier rather than as an absorption enhancer. The average particle size of the SAE-CD is large enough to preclude (for the most part) pulmonary deposition thereof. Following release from the DPI device, the SAE-CD-containing particles dissociate from the active agent-containing particles in the buccal cavity or throat, after which the active agent-containing particles continue deeper into the respiratory tract. The physiochemical and morphological properties of the SAE-CD are easily modified to permit optimization of active agent and carrier interactions. Drugs having a positive, neutral or negative electrostatic charge can be delievered by DPI when SAE-CD is used as a carrier.
公开/授权文献
- EP2708225A1 DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin 公开/授权日:2014-03-19
信息查询